| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 42.620.553 $ | 95,93 | 15.543.744 | |||||||
| DEFINIUM THERAPEUTICS INC | DEFINIUM THERAPEUTICS INC COM SHS | EC | 24477V105 | Long | Börsenkurs (Stufe 1) | 5.709.762 $ | 12,85 | 121.381 | |
| COMPASS PATHWAYS PLC | COMPASS PATHWAYS PLC SPONSORED ADS | EC | 20451W101 | Long | Börsenkurs (Stufe 1) | 5.089.005 $ | 11,45 | 359.647 | |
| ATAIBECKLEY INC | ATAIBECKLEY INC COM SHS | EC | 04650F101 | Long | Börsenkurs (Stufe 1) | 4.652.841 $ | 10,47 | 882.892 | |
| RELMADA THERAPEUTICS INC | RELMADA THERAPEUTICS INC COM | EC | 75955J402 | Long | Börsenkurs (Stufe 1) | 3.037.195 $ | 6,84 | 438.901 | |
| NRX PHARMACEUTICALS INC | NRX PHARMACEUTICALS INC COM NEW | EC | 629444209 | Long | Börsenkurs (Stufe 1) | 2.695.384 $ | 6,07 | 659.018 | |
| NEUROCRINE BIOSCIENCES INC | NEUROCRINE BIOSCIENCES INC COM | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 1.947.085 $ | 4,38 | 11.553 | |
| CYBIN INC | CYBIN INC COM NEW | EC | 23256X407 | Long | Börsenkurs (Stufe 1) | 1.934.820 $ | 4,35 | 292.711 | |
| GH RESEARCH PLC | GH RESEARCH PLC ORDINARY SHARES | EC | IE000GID8VI0 | Long | Börsenkurs (Stufe 1) | 1.915.657 $ | 4,31 | 71.267 | |
| ALKERMES PLC | ALKERMES PLC SHS | EC | IE00B56GVS15 | Long | Börsenkurs (Stufe 1) | 1.909.169 $ | 4,30 | 36.438 | |
| ALTO NEUROSCIENCE INC | ALTO NEUROSCIENCE INC COM SHS | EC | 02157Q109 | Long | Börsenkurs (Stufe 1) | 1.867.040 $ | 4,20 | 70.748 | |
| ABBVIE INC | ABBVIE INC COM | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 1.841.502 $ | 4,14 | 7.318 | |
| BRIGHT MINDS BIOSCIENCES INC | BRIGHT MINDS BIOSCIENCES INC COM NEW | EC | 10919W405 | Long | Börsenkurs (Stufe 1) | 1.704.035 $ | 3,84 | 24.274 | |
| JOHNSON & JOHNSON | JOHNSON & JOHNSON COM | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 1.602.043 $ | 3,61 | 6.308 | |
| SUPERNUS PHARMACEUTICALS INC | SUPERNUS PHARMACEUTICALS INC COM | EC | 868459108 | Long | Börsenkurs (Stufe 1) | 1.284.513 $ | 2,89 | 27.618 | |
| NEUPHORIA THERAPEUTICS INC | NEUPHORIA THERAPEUTICS INC COM | EC | 64136E102 | Long | Börsenkurs (Stufe 1) | 1.105.212 $ | 2,49 | 252.909 | |
| NEURONETICS INC | NEURONETICS INC COM | EC | 64131A105 | Long | Börsenkurs (Stufe 1) | 965.634 $ | 2,17 | 742.795 | |
| QUANTUM BIOPHARMA LTD | QUANTUM BIOPHARMA LTD CL B SUB VTG SHS | EC | 74764Y205 | Long | Börsenkurs (Stufe 1) | 736.902 $ | 1,66 | 203.564 | |
| OPTIMI HEALTH CORP | OPTIMI HEALTH CORP COMMON SHARES | EC | 68405H308 | Long | Börsenkurs (Stufe 1) | 523.221 $ | 1,18 | 102.794 | |
| PASITHEA THERAPEUTICS CORP | PASITHEA THERAPEUTICS CORP COM NEW | EC | 70261F202 | Long | Börsenkurs (Stufe 1) | 483.213 $ | 1,09 | 937.550 | |
| SILO PHARMA INC | SILO PHARMA INC COM | EC | 82711P300 | Long | Börsenkurs (Stufe 1) | 469.364 $ | 1,06 | 75.582 | |
| PSYENCE BIOMEDICAL LTD | PSYENCE BIOMEDICAL LTD COM SHS | EC | 74449F407 | Long | Börsenkurs (Stufe 1) | 373.883 $ | 0,84 | 122.184 | |
| INCANNEX HEALTHCARE INC | INCANNEX HEALTHCARE INC COM | EC | 45333F208 | Long | Börsenkurs (Stufe 1) | 228.864 $ | 0,52 | 60.868 | |
| NUMINUS WELLNESS INC | NUMINUS WELLNESS INC COM | EC | 67054W103 | Long | Börsenkurs (Stufe 1) | 209.083 $ | 0,47 | 8.482.082 | |
| IGC PHARMA INC | IGC PHARMA INC COM NEW | EC | 45408X308 | Long | Börsenkurs (Stufe 1) | 184.547 $ | 0,42 | 678.480 | |
| VISTAGEN THERAPEUTICS INC | VISTAGEN THERAPEUTICS INC COM | EC | 92840H400 | Long | Börsenkurs (Stufe 1) | 99.133 $ | 0,22 | 438.643 | |
| ENVERIC BIOSCIENCES INC | ENVERIC BIOSCIENCES INC COM SHS | EC | 29405E505 | Long | Börsenkurs (Stufe 1) | 48.875 $ | 0,11 | 35.417 | |
| CLEARMIND MEDICINE INC | CLEARMIND MEDICINE INC COM SHS | EC | 185053600 | Long | Börsenkurs (Stufe 1) | 2.572 $ | 0,01 | 1.169 | |
| QUANTUM BIOPHARMA | QUANTUM BIOPHARMA | EC | Long | Schätzwert (Stufe 3) | 0 $ | 0,00 | 46.617 | ||
| UNBUZZD WELLNESS INC | UNBUZZD WELLNESS INC N/C FROM QUANTUM BIOPHARMA LTD TO UNBUZZ | EC | 90429T100 | Long | Schätzwert (Stufe 3) | 0 $ | 0,00 | 263.236 | |
| SAGE THERAPEUTICS INC | SAGE THERAPEUTICS INC | EC | Long | Börsenkurs (Stufe 1) | 0 $ | 0,00 | 89.780 | ||
| 42.620.553 $ | 95,93 | 15.543.744 |